Online Ahead of Print

 

On the Paclitaxel Meta-Analysis: A Conversation With Konstantinos Katsanos, MD

Dr. Katsanos discusses the methods and findings of his group’s meta-analysis, the patient-level data presented in response, and potential next steps.

News

 

FDA to Convene Advisory Committee Meeting After Preliminary Review Finds Signal of Increased Mortality With Paclitaxel-Eluting Devices

March 15, 2019 -- The FDA has announced that its preliminary review of the long-term follow-up data on paclitaxel-coated balloons and paclitaxel-eluting stents to treat periph…

No Long-Term Increased Mortality Seen in Medicare PAD Patients Treated With Peripheral DES

March 14, 2019 -- Findings from an investigation examining long-term mortality between drug-eluting stent (DES) and bare-metal stent (BMS) implantation in patients with a prin…

FDA Approves BD's Venovo Venous Stent to Treat Iliofemoral Venous Occlusive Disease

March 14, 2019 -- BD (Becton, Dickinson and Company) announced that the FDA has granted premarket approval for the Venovo venous stent for the treatment of iliofemoral venous …

Study Analyzes Patency Outcomes of DCB Angioplasty in Hemodialysis Circuits

March 14, 2019 -- Findings from a systematic review and meta-analysis assessing patency outcomes following drug-coated balloon (DCB) angioplasty in hemodialysis circuits were …

BD's Covera Vascular Stent Approved for Patients With End-Stage Renal Disease

March 14, 2019 -- BD (Becton, Dickinson and Company) has received FDA premarket approval of the Covera vascular covered stent for patients with end-stage renal disease who are…

FDA Grants Saranas De Novo Designation for the Early Bird Bleed Monitoring System

March 5, 2019 -- Saranas Inc. announced that it has been granted de novo classification by the FDA for its Early Bird bleed monitoring system for interventions where the femor…

Click here for more News coverage

Current Supplement

Sponsored by GORE & ASSOCIATES

Looking at the Full Scope of PAD

Cases, Techniques, and Economic Considerations for Complex Disease.

Current European Supplement

Sponsored by BIOTRONIK

Maximizing Outcomes. Minimizing Burden.

How to React in the SFA

Paclitaxel In PAD

Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 

Featured Center

 

Embolization

 
Vascular Market Price  Change
Abbott Laboratories $78.43  -1.79%
AstraZeneca PLC $42.54  0.06%
Avinger $1.07  20.22%
Becton Dickinson and Co $243.04  -4.28%
Boston Scientific Corporation $38.06  -5.36%
Cardinal Health $49.70  -1.13%
Cardiovascular Systems Inc. $39.18  -1.30%
Edwards Lifesciences Corp. $190.53  6.00%
Endologix Inc. $6.95  -1.84%
Vascular Market Price  Change
Johnson and Johnson $137.08  -0.38%
Medtronic, Inc. $91.69  -2.24%
Merit Medical Systems, Inc. $59.89  -1.64%
Penumbra, Inc. $151.27  -2.61%
Philips $40.79  -0.87%
Stryker $193.03  -0.52%
Teleflex Inc. $298.20  -1.55%
The Medicines Company $27.09  -0.15%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.